Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Emergence Agitation in Children
NCT03171740Phase 3Completed
- Sponsor
- Hospital Universitário de Brasília
- Start
- Jun 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine in emergence delirium (ED), sponsored by Hospital Universitário de Brasília. Primary endpoint: Emergence agitation. Started Jun 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT03171740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03171740.